" /> Mucolipidosis II alpha/beta - CISMeF





Preferred Label : Mucolipidosis II alpha/beta;

CISMeF acronym : ICD; ML II;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Ml II alpha/beta; I-cell disease; ML II; Mucolipidosis II; ICD;

Description : Mucolipidosis type II alpha/beta is an autosomal recessive disorder characterized clinically by short stature, skeletal abnormalities, cardiomegaly, and developmental delay. The disorder is caused by a defect in proper lysosomal enzyme phosphorylation and localization, which results in accumulation of lysosomal substrates. It is phenotypically more severe than the allelic disorder mucolipidosis type III alpha/beta (summary by Paik et al., 2005).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the N-acetylglucosamine-1-phosphotransferase, alpha/beta subunits gene (GNPTAB, 607840.0003);

Laboratory abnormalities : Normal to mildly increased mucopolysacchariduria; Increased serum beta-hexosaminidase (10-20x); Increased serum iduronate sulfatase (10-20x); Increased serum arylsulfatase A (10-20x); Deficiency of N-acetylglucosamine-1-phosphotransferase; Inclusion bodies (membrane-bound vacuoles) in fibroblasts;

Prefixed ID : #252500;

Details


You can consult :


Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.